Clinical cure rates in subjects treated with azithromycin for community-acquired respiratory tract infections caused by azithromycin-susceptible or azithromycin-resistant Streptococcus pneumoniae : analysis of Phase 3 clinical trial data—authors' response: Figure 1.
Zhanel, George G., Wolter, Kevin D., Karlowsky, James A.Language:
english
Journal:
Journal of Antimicrobial Chemotherapy
DOI:
10.1093/jac/dkv234
Date:
August, 2015
File:
PDF, 108 KB
english, 2015